InvestorsHub Logo
Followers 35
Posts 2774
Boards Moderated 0
Alias Born 11/04/2013

Re: namtae post# 313336

Wednesday, 04/03/2019 2:44:03 PM

Wednesday, April 03, 2019 2:44:03 PM

Post# of 402260
The potential ability of isradipine to slow progression of disability in PD; representing the strongest preclinical and clinical rationale of any past or current putative disease-modifying agent for PD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News